A comprehensive new trial offers practical insights for healthcare systems seeking to implement effective antimicrobial stewardship. First, point-of-care C-reactive protein and serum amyloid A testing paired with clinical decision support can cut antibiotic prescribing by 61%—demonstrating that biomarker-guided approaches are far more effective than education alone.
Second, achieving dramatic reductions in prescribing does not compromise patient care. Safety outcomes remained equivalent between intervention and control groups, with no increase in hospitalizations or return visits, challenging the assumption that lower prescribing rates inevitably lead to worse outcomes. Third, healthcare providers embraced the system enthusiastically, with 94% indicating they would recommend the intervention—suggesting high implementation feasibility.
These findings underscore that antimicrobial stewardship requires more than awareness; it demands structured tools, real-time diagnostic support, and training aligned with evidence-based guidelines. The trial involved 4,982 patients across 76 rural clinics in China.
Read the full article on GMJ Newsroom.
Was this article helpful?
